Trastuzumab con pertuzumab en cáncer de mama HER2 positivo: [junio de 2022] / Trastuzumab with pertuzumab in HER2-positive breast cancer: [June 2022]
Buenos Aires; IECS; jun. 2022.
Non-conventional
in Spanish
| BRISA/RedTESA
| ID: biblio-1518848
Responsible library:
BR1.1
Subject(s)
Full text:
Available
Collection:
Tematic databases
Database:
BRISA/RedTESA
Main subject:
Breast Neoplasms
/
Immunoglobulin G
/
Trastuzumab
Type of study:
Health technology assessment
Limits:
Humans
Language:
Spanish
Year:
2022
Document type:
Non-conventional
